#Trump archivos - Metro Latino USA | Metrolatino USA News Site

06

Jan

0 Comments

Actualidad, DMV#Trump, arrestados, Capitolio, disturbios, heridos, muerto, Washington

Democracia en jaque

Un muerto, 6 heridos, 13 arrestados en disturbios en el Capitolio de Washington. Foto: Lenin Nolly/MLNews Por Santiago David Távara WASHINGTON, D.C. (MLNews).- La ciudad de Washington DC sufrió un asalto a la democracia en plena pandemia, protagonizada por miles de manifestantes descontentos con la derrota del presidente republicano Donald…

11

Apr

By MetroLatinoUSA

0 Comments

Opinión#Trump, americas, cumbre, lima, maduro

“Hombres fuertes” brillarán por su ausencia en la Cumbre de las Américas

Por Santiago D. Távara En la Cumbre de las Américas brillarán por su ausencia los “hombres fuertes” del hemisferio: el polémico presidente de Estados Unidos, Donald Trump, y el mandatario venezolano Nicolás Maduro, la pregunta es si en realidad iban a contribuir positivamente en el encuentro de mandatarios, auspiciada por…

10

Apr

By S T

0 Comments

Economía, Negocios y Finanzas, Latin News#siria, #summit2018, #summitamericas, #Trump

Trump to Skip South America Summit to Focus of Siria

WASHINGTON — The White House says President Donald Trump will skip an upcoming summit in South America and will remain in the United States to "oversee the American response to Syria and to monitor developments around the world." White House spokeswoman Sarah Huckabee Sanders said in a statement Tuesday that…

08

Apr

By MetroLatinoUSA

0 Comments

Opinión#peru, #Trump, americas, cumbre

América Latina debilitada recibe a un Trump enardecido en Cumbre de las Américas

Por Santiago D. Távara América Latina, con gobiernos debilitados por el escándalo de corrupción relacionado con la empresa brasileña Odebrecht, se encuentra con un vacío de liderazgo para frenar la retórica del presidente de Estados Unidos, Donald Trump, que insiste en la construcción de un muro en la frontera con…

24

Feb

By S T

0 Comments

Actualidad, Comunidad, Latinoamérica y Mundo#PPK, #Trump

Kuczynski y Trump en la Casa Blanca

#Trump

Democracia en jaque

“Hombres fuertes” brillarán por su ausencia en la Cumbre de las Américas

Trump to Skip South America Summit to Focus of Siria

América Latina debilitada recibe a un Trump enardecido en Cumbre de las Américas

Kuczynski y Trump en la Casa Blanca

Research Results from Ontada HOPE Studies Presented at ASCO 2023 Illuminate How Social Determinants of Health Impact Different Patient Populations with Triple-Negative Breast Cancer

Puma Biotechnology Announces Presentation of Biomarker Findings from a Phase II Study of Alisertib with Paclitaxel versus Paclitaxel Alone in Metastatic or Locally Recurrent Breast Cancer at the 2023 ASCO Annual Meeting

Four-Year Outcomes from Phase 3 CheckMate -9LA Trial Show Durable, Long-Term Survival with Opdivo (nivolumab) Plus Yervoy (ipilimumab) with Two Cycles of Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer

Nucleai and Mayo Clinic BioPharma Diagnostics Announce Strategic Collaboration to Transform Digital Pathology for Drug Development and Clinical Practice

TAGRISSO® achieved unprecedented survival in early-stage EGFR-mutated lung cancer, with 88% of patients alive at five years in ADAURA Phase III trial

ELAHERE® Demonstrates 35% Reduction in the Risk of Disease Progression or Death Versus Chemotherapy in FRα-Positive Platinum-Resistant Ovarian Cancer

Research Results from Ontada HOPE Studies Presented at ASCO 2023 Illuminate How Social Determinants of Health Impact Different Patient Populations with Triple-Negative Breast Cancer

Puma Biotechnology Announces Presentation of Biomarker Findings from a Phase II Study of Alisertib with Paclitaxel versus Paclitaxel Alone in Metastatic or Locally Recurrent Breast Cancer at the 2023 ASCO Annual Meeting

Four-Year Outcomes from Phase 3 CheckMate -9LA Trial Show Durable, Long-Term Survival with Opdivo (nivolumab) Plus Yervoy (ipilimumab) with Two Cycles of Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer

Nucleai and Mayo Clinic BioPharma Diagnostics Announce Strategic Collaboration to Transform Digital Pathology for Drug Development and Clinical Practice

TAGRISSO® achieved unprecedented survival in early-stage EGFR-mutated lung cancer, with 88% of patients alive at five years in ADAURA Phase III trial

ELAHERE® Demonstrates 35% Reduction in the Risk of Disease Progression or Death Versus Chemotherapy in FRα-Positive Platinum-Resistant Ovarian Cancer

Research Results from Ontada HOPE Studies Presented at ASCO 2023 Illuminate How Social Determinants of Health Impact Different Patient Populations with Triple-Negative Breast Cancer

Puma Biotechnology Announces Presentation of Biomarker Findings from a Phase II Study of Alisertib with Paclitaxel versus Paclitaxel Alone in Metastatic or Locally Recurrent Breast Cancer at the 2023 ASCO Annual Meeting

Four-Year Outcomes from Phase 3 CheckMate -9LA Trial Show Durable, Long-Term Survival with Opdivo (nivolumab) Plus Yervoy (ipilimumab) with Two Cycles of Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer

Nucleai and Mayo Clinic BioPharma Diagnostics Announce Strategic Collaboration to Transform Digital Pathology for Drug Development and Clinical Practice

TAGRISSO® achieved unprecedented survival in early-stage EGFR-mutated lung cancer, with 88% of patients alive at five years in ADAURA Phase III trial

ELAHERE® Demonstrates 35% Reduction in the Risk of Disease Progression or Death Versus Chemotherapy in FRα-Positive Platinum-Resistant Ovarian Cancer